Project Details
Description
This project aims to study the regulatory challenges to the development of new vaccines. This project will engage and build upon the expertise of a multidisciplinary team as they investigate the important evolving relationships between science, evidence and policy. In doing so, the study will fill a crucial gap in the literature by drawing national and international comparisons and by generating novel insights on how emerging regulation impacts on the development of new vaccines. A multi-sited ethnographic approach is employed with three cases being investigated and compared. Study 1 is an examination of the new questions and issues for the field of cervical cancer prevention with the availability of vaccination against high risk HPV. Study 2 examines the innovation and production of the pandemic influenza vaccine in Canada. Study 3 presents a contrasting approach of the African Meningitis vaccine and the implementation of the regulatory framework in Burkina Faso, from which developed and developing country comparisons and lessons are drawn.
Status | Finished |
---|---|
Effective start/end date | 10/1/09 → 9/30/10 |
Funding
- Institute of Health Services and Policy Research: US$86,733.00
ASJC Scopus Subject Areas
- Immunology
- Public Health, Environmental and Occupational Health
- Health Policy
- Medicine (miscellaneous)